In parallel, JNK1/2 inhibition abrogated the growth advantage and enhanced migration effect prompted by ASPA knockdown in PCa cells (P < 0.01; Fig. 5k; Additional file 1: Fig. S4e, f). The gene discussed is MAPK8; the disease is posterior cortical atrophy.